Lisofylline ameliorates intestinal and hepatic injury induced by hemorrhage and resuscitation in rats

Critical Care Medicine

Volumn 28, Issue 5, 2000, Pages 1540-1549

  Wattanasirichaigoon, Somkiat ^a   Menconi, Michael J ^a   Fink, Mitchell P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenosine triphosphate; Glutathione; Liver; Permeability intestinal; Shock

Indexed keywords

ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; FREE RADICAL; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; INTERLEUKIN 8; LISOFYLLINE; LIVER ENZYME; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; ENZYME ACTIVITY; INTESTINE INJURY; INTESTINE MUCOSA; LASER DOPPLER FLOWMETRY; LIVER INJURY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SHOCK; STRUCTURE ACTIVITY RELATION;

EID: 0034030237     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200005000-00047     Document Type: Article

References (48)

1. 1. Baker JW, Deitch EA, Li M, et al: Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 1988; 28:896-906
2. 2. Kerner J, Wang P, Chaudry IH: Impaired gut lipid absorptive capacity after trauma-hemorrhage and resuscitation. Am J Physiol 1995; 269:R869-R873
3. 2, restores gut absorptive capacity early after trauma-hemorrhagic shock. Am J Physiol 1993; 264:R977-R983
4. 4. Russell DH, Barreto JC, Klemm K, et al: Hemorrhagic shock increases gut macromolecular permeability in the rat. Shock 1995; 4:50-55
5. 5. Aranow JS, Fink MP: Determinants of intestinal barrier failure in critical illness. Br J Aneasth 1996; 77:71-81
6. 6. Deitch EA, Bridges W, Ma L, et al: Hemorrhagic shock-induced bacterial translocation: The role of neutrophils and hydroxyl radicals. J Trauma 1990; 30:942-952
7. 7. Deitch EA, Bridges W, Baker J, et al: Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 1988; 104: 191-198
8. 8. Rollwagen FM, Li YY, Pacheco ND, et al: Systemic bacteraemia following hemorrhagic shock in mice: Alleviation with oral interleukin 6. Cytokine 1996; 8:121-129
9. 9. Abraham E, Bursten S, Shenkar R, et al: Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J Exp Med 1995; 181:569-575
10. 10. Waxman K, Daughters K, Aswani S, et al: Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock. Crit Care Med 1996; 24: 1724-1728
11. 11. Wattanasirichaigoon S, Menconi MJ, Delude RL, et al: Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. Shock 1999; 11:269-275
12. 12. Hybertson BM, Bursten SL, Leff JA, et al: Lisofylline prevents leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally. J Appl Physiol 1997; 82: 226-232
13. 13. Guidot DM, Bursten SL, Rice CC, et al: Modulating phosphatidic acid metabolism decreases oxidative injury in rat lungs. Am J Physiol 1997; 273:L957-L966
14. 14. Rice GC, Brown PA, Nelson RJ, et al: Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Soc Natl Acad Sci USA 1994; 91: 3857-3861
15. 15. Beulter E, Duron O, Kelly BM: Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61:882-888
16. 16. Bursten SL, Federighi D, Wald J, et al: Lisofylline causes a rapid and prolonged suppression of serum levels of free fatty acids. J Pharmacol Exp Ther 1998; 284:337-345
17. 17. Chiu C-J, McArdle AH, Brown R, et al: Intestinal mucosal lesions in low flow states. Arch Surg 1970; 101:478-483
18. 18. Bright JJ, Du C, Coon M, et al: Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J Immunol 1998; 161:7015-7022
19. 19. Rice GC, Rosen J, Weeks R, et al: CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock 1994; 1:254-266
20. 20. Edwards MJ, Heniford BT, Klar EA, et al: Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves anti-tumor efficacy. J Clin Invest 1992; 90: 637-641
21. 21. Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990; 172:391-394
22. 22. Doherty GM, Jensen JC, Alexander HR, et al: Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991; 110: 192-198
23. 23. Schade UP: Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 1990; 31:171-181
24. 24. Lechner AJ, Rouben LR, Potthoff LH, et al: Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ Shock 1993; 39:306-315
25. 25. Edwards MJ, Abney DL, Miller FN: Pentoxifylline inhibits interleukin-2-induced leukocyte-endothelial adherence and reduces systemic toxicity. Surgery 1991; 110:199-204
26. 26. Tighe D, Hynd J, Boghossian S, et al: Pre-treatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model. Crit Care Med 1990; 18:184-189
27. 27. Flynn WJ, Cryer HG, Garrison RN: Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock. Surgery 1991; 110:350-356
28. 28. Sinha B, Semmler J, Eisenhut T, et al: Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur J Immunol 1995; 25:147-153
29. 29. Semmler J, Gebert U, Eisenhut T, et al: Xanthine derivatives: Comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 1993; 78: 520-525
30. 30. Lee KS, Cottam HB, Houglum K, et al: Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity. Am J Physiol 1997; 273: G1094-G1100
31. 31. Nordin A, Mildh L, Mäkisalo H, et al: Hepatosplanchnic and peripheral tissue oxygenation during treatment of hemorrhagic shock: The effects of pentoxifylline administration. Ann Surg 1998; 228:741-747
32. 32. Wang P, Zheng F, Stepp KJ, et al: Pentoxifylline attenuates the depressed endothelial cell function and vascular contractility following trauma and hemorrhagic shock. J Trauma 1995; 39:121-127
33. 33. Wattanasirichaigoon S, Menconi MJ, Delude RL, et al: Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock 1999; 12:127-133
34. 34. Salzman AL, Menconi MJ, Unno N, et al: Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 1995; 268:G361-G373
35. 35. Madara JL: Loosening tight junctions: Lessons from the intestine. J Clin Invest 1989; 83:1089-1094
36. 36. Denker BM, Nigam SK: Molecular structure and assembly of the tight junction. Am J Physiol 1998; 264:F1-F9
37. BBe monolayers. Am J Physiol 1996; 270:G1010-G1021
38. 38. Ma TY, Hollander D, Tran LT, et al: Cytoskeletal regulation of Caco-2 intestinal monolayer paracellular permeability. J Cell Physiol 1995; 164:533-545
39. 39. Hinshaw DB, Burger JM, Miller MT, et al: ATP depletion induces an increase in the assembly of a labile pool of polymerized actin in endothelial cells. Am J Physiol 1993; 264: C1171-C1179
40. 40. Pollard TD: Actin. Curr Opin Cell Biol 1990; 2:33-40
41. 41. Walsh CJ, Carey PD, Cook DJ, et al: Anti-CD18 antibody attenuates neutropenia and alveolare capillary-membrane injury during gram-negative sepsis. Surgery 1991; 110: 205-212
42. 42. Guice KS, Oldham KT, Caty MG, et al: Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg 1989; 210:740-747
43. 43. Jaeschke H, Farhood A, Smith CW: Contribution of complement-stimulated hepatic macrophages and neutrophils to endotoxin-induced liver injury in rats. Hepatology 1994; 19:973-979
44. 44. Sato T, Shinzawa H, Abe Y, et al: Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody. J Leukocyte Biol 1993; 53:144-150
45. 45. Granger DN: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988; 255:H1269-H1275
46. 46. Hernandez LA, Grisham MB, Twohig B, et al: Role of neutrophils in ischemia-reperfusion induced microvascular injury. Am J Physiol 1987; 253:H699-H703
47. 47. Kurtel H, Fujimoto K, Zimmerman BJ, et al: Ischemia-reperfusion-induced mucosal dysfunction: Role of neutrophils. Am J Physiol 1991; 261:G490-G496
48. 48. Oka Y, Hasegawa N, Nakayama M, et al: Selective down-regulation of neutrophils by a phosphatidic acid generation inhibitor in a porcine sepsis model. J Surg Res 1999; 81:147-155